A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis

Completed · Phase 2

Conditions studied: Seasonal Allergic Rhinitis

In brief

The purpose of this trial is to determine the safety, efficacy and tolerability of two doses of the study drug compared to placebo for the treatment of subjects with seasonal allergic rhinitis.

Key facts

Study ID

NCT00407927

Run by

Merck Sharp & Dohme LLC

People needed

571

Starts

2006-12-01

Expected to finish

2007-03-01

Last updated by the study team

2015-10-12

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A documented history of seasonal allergic rhinitis to mountain cedar pollen

You may not qualify if…

• Significant medical condition
• Cardiovascular abnormality
• Have a significant physical obstruction in the nose
• Started or had a change in immunotherapy within the 30 days prior to
• screening
• Have nasal ulceration(s) or any active nasal bleeding
• Require use of allergy medications during the study
• Require use of asthma medications other than as needed albuterol

Where it is running

• Allergy & Asthma Associates — Austin, Texas, United States
• Lovelace Scientific Resources, Inc. — Austin, Texas, United States
• Kerrville Research Associates — Kerrville, Texas, United States
• Central Texas Health Research — New Braunfels, Texas, United States
• Biogenics Research Institute — San Antonio, Texas, United States
• Sylvana Research Associates — San Antonio, Texas, United States
• Allergy Asthma Research Institute — Waco, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.